Drug Profile
MAN 01 companion diagnostic - Q BioMed/Washington University in St. Louis
Alternative Names: GDF 15 companion diagnostic - Q Biomed/Washington University in St. Louis; GDF-15 - Q BioMed; GDF15 - Q BioMed/Washington University in St. Louis; MAN 11 companion diagnostic - Q Biomed/Washington University in St. LouisLatest Information Update: 28 Jan 2024
Price :
$50
*
At a glance
- Originator Washington University
- Developer Q BioMed; Washington University
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Glaucoma
Most Recent Events
- 28 Jan 2024 No recent reports of development identified for clinical-Phase-Unknown development in Glaucoma(Diagnosis) in USA
- 27 Sep 2022 Q BioMed has patent protection for MAN 01 companion diagnostic in Europe
- 31 Dec 2020 Clinical trials in Glaucoma (Diagnosis) in USA (unspecified route) before December 2020